Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Jonnyboy85on May 31, 2021 4:44pm
106 Views
Post# 33297652

RE:RE:RE:RE:RE:The 2:1 consolidation

RE:RE:RE:RE:RE:The 2:1 consolidationYou don't lose shares man, you obviously don't understand what a consolidation is. To make it as simple as possible, they take 2 shares worth say $1 and make them 1 share worth $2, so if you had $20000 in shares before, you'll have $20000 in shares after. For you and me it has zero impact, the benefits are that if we say get into the $2.50 to $3 range we can uplist to the naz with a quick consolidation by turning those shares into $5-$6. I'm sure you want the naz right? This in turn also reduces the total count of shares which makes the day trading, swing trading, and the algorithmic trading we've seen over the years much more difficult. Just look at the posts, the only people talking isht about the consolidation is the spam basher accounts, because they know its bad for them. wake up man, you wanted to be off my list of bashers but you seem to be aligning yourself with their motivations, which are most definitely not for the common investors benefit. The Naz makes us more attractive to potential buyouts, better analysts, attracts better partners, higher share price makes raising funds more easy with less dilution, and less opportunity to manipulative traders, and thats all without talking about the tighter regulations in the us when it comes to short and distort schemes. Not to mention some people don't invest in a company unless they trade above say $1 or $5 or whatever and if you want to attract mutual funds and institutional investors that buy and hold for decades these are some of the things that might be necessary.   
<< Previous
Bullboard Posts
Next >>